UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

Probability of Success: A Crucial Concept to Inform Decision Making in Pharmaceutical Research and Development

Clinical pharmacology and therapeutics, 2022-05, Vol.111 (5), p.1001-1003

2022

Volltextzugriff (PDF)

Exposure-Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation

Journal of clinical pharmacology, 2009-11, Vol.49 (11), p.1297-1308

2009

Volltextzugriff (PDF)

How modeling and simulation have enhanced decision making in new drug development

Journal of pharmacokinetics and pharmacodynamics, 2005-04, Vol.32 (2), p.185-197

2005

Volltextzugriff (PDF)

Performance Characteristics for Some Typical QT Study Designs Under the ICH E-14 Guidance

Journal of clinical pharmacology, 2008-02, Vol.48 (2), p.215-224

2008

Volltextzugriff (PDF)

Fostering Culture and Optimizing Organizational Structure for Implementing Model-Based Drug Development

Journal of clinical pharmacology, 2010-09, Vol.50 (S9), p.146S-150S

2010

Volltextzugriff (PDF)

A Perspective on the Use of Concentration-QT Modeling in Drug Development

Journal of clinical pharmacology, 2008-01, Vol.48 (1), p.9-12

2008

Volltextzugriff (PDF)

A Single‐Blind, Crossover Comparison of the Pharmacokinetics and Cognitive Effects of a New Diazepam Rectal Gel with Intravenous Diazepam

Epilepsia (Copenhagen), 1998-05, Vol.39 (5), p.520-526

1998

Volltextzugriff (PDF)

Evaluation of mixture modeling with count data using NONMEM

Journal of pharmacokinetics and pharmacodynamics, 2003-06, Vol.30 (3), p.167-183

2003

Volltextzugriff (PDF)

Truncated area under the curve as a measure of relative extent of bioavailability : Evaluation using experimental data and Monte Carlo simulations

Pharmaceutical research, 1998-10, Vol.15 (10), p.1621-1629

1998

Volltextzugriff (PDF)

Acceleration of digoxin clearance by activated charcoal

Clinical pharmacology and therapeutics, 1985-04, Vol.37 (4), p.367-371

1985

Volltextzugriff (PDF)

Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma

Annals of allergy, asthma, & immunology, 1999-04, Vol.82 (4), p.377-382

1999

Volltextzugriff (PDF)

Comparison of different methods to evaluate population dose-response and relative potency : Importance of interoccasion variability

Journal of pharmacokinetics and biopharmaceutics, 1999-02, Vol.27 (1), p.67-83

1999

Volltextzugriff (PDF)

Effects of age on the protein binding and disposition of propranolol stereoisomers

Clinical pharmacology and therapeutics, 1990-04, Vol.47 (4), p.447-455

1990

Volltextzugriff (PDF)

PHARMACODYNAMICS

Pharmacology and Therapeutics: Principles to Practice, 2009, p.203-218

First Edition, 2009

Volltextzugriff (PDF)

Labetalol pharmacokinetics and pharmacodynamics: Evidence of stereoselective disposition

Clinical pharmacology and therapeutics, 1990-11, Vol.48 (5), p.509-519

1990

Volltextzugriff (PDF)

Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers

Clinical pharmacology and therapeutics, 1990-05, Vol.47 (5), p.584-591

1990

Volltextzugriff (PDF)

Effect of calcium channel blockers on theophylline disposition

Clinical pharmacology and therapeutics, 1988-07, Vol.44 (1), p.29-34

1988

Volltextzugriff (PDF)

Altered β-Adrenergic Sensitivity and Protein Binding to 1-Propranolol in the Elderly

Journal of cardiovascular pharmacology, 1990-11, Vol.16 (5), p.702-707

1990

Volltextzugriff (PDF)

The effect of diltiazem on the disposition of encainide and its active metabolites

Clinical pharmacology and therapeutics, 1989-12, Vol.46 (6), p.668-673

1989

Volltextzugriff (PDF)

Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568

Clinical pharmacology and therapeutics, 1999-01, Vol.65 (1), p.40-49

1999

Volltextzugriff (PDF)

Nonlinear Pharmacokinetics of Unbound Propranolol after Oral Administration

Journal of pharmaceutical sciences, 1987-07, Vol.76 (7), p.521-524

1987

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of dilevalol

Clinical pharmacology and therapeutics, 1989-12, Vol.46 (6), p.648-656

1989

Volltextzugriff (PDF)

Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-Davis

Clinical pharmacokinetics, 2000-05, Vol.38 (5), p.449-459

2000

Volltextzugriff (PDF)

Population pharmacokinetics of terfenadine

Pharmaceutical research, 1996-06, Vol.13 (6), p.832-838

1996

Volltextzugriff (PDF)

Releasing the human spirit in developing drugs: Increasing clinical pharmacokinetics productivity

International journal of pharmaceutical medicine, 2004, Vol.18 (1), p.13-17

2004

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(81)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Probability of Success: A Crucial Concept to Inform Decision Making in Pharmaceutical Research and Development

Exposure-Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation

How modeling and simulation have enhanced decision making in new drug development

Performance Characteristics for Some Typical QT Study Designs Under the ICH E-14 Guidance

Fostering Culture and Optimizing Organizational Structure for Implementing Model-Based Drug Development

A Perspective on the Use of Concentration-QT Modeling in Drug Development

A Single‐Blind, Crossover Comparison of the Pharmacokinetics and Cognitive Effects of a New Diazepam Rectal Gel with Intravenous Diazepam

Evaluation of mixture modeling with count data using NONMEM

Truncated area under the curve as a measure of relative extent of bioavailability : Evaluation using experimental data and Monte Carlo simulations

Acceleration of digoxin clearance by activated charcoal

Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma

Comparison of different methods to evaluate population dose-response and relative potency : Importance of interoccasion variability

Effects of age on the protein binding and disposition of propranolol stereoisomers

PHARMACODYNAMICS

Labetalol pharmacokinetics and pharmacodynamics: Evidence of stereoselective disposition

Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers

Effect of calcium channel blockers on theophylline disposition

Altered β-Adrenergic Sensitivity and Protein Binding to 1-Propranolol in the Elderly

The effect of diltiazem on the disposition of encainide and its active metabolites

Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568

Nonlinear Pharmacokinetics of Unbound Propranolol after Oral Administration

Pharmacokinetics and pharmacodynamics of dilevalol

Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-Davis

Population pharmacokinetics of terfenadine

Releasing the human spirit in developing drugs: Increasing clinical pharmacokinetics productivity

Suchergebnisse filtern